How much funding has Haihe Pharmaceutical raised?

Haihe Pharmaceutical has raised $318.0M in total funding, most recently a Series B round.

When was Haihe Pharmaceutical founded?

Haihe Pharmaceutical was founded in 2011.

Where is Haihe Pharmaceutical headquartered?

Haihe Pharmaceutical is headquartered in Shanghai, China.

What industry is Haihe Pharmaceutical in?

Haihe Pharmaceutical operates in Biotech, Healthcare.

How many employees does Haihe Pharmaceutical have?

Haihe Pharmaceutical has 201-500 employees.

Haihe Pharmaceutical

Haihe brings life-saving therapies to cancer patients worldwide.

Shanghai, China · Founded 2011 · $318.0M raised

Biotech

Healthcare

Headquarters: Shanghai
Employees: 201–500
Founded: 2011
Business Model: B2B

Website: haihepharma.com
Total Funding: $318.0M
Last Round: $171.0M Series BJul 2020

About

Haihe Biopharma is an innovation-driven biotechnology company in China focused on the discovery, development, production, and commercialization of innovative oncology drugs. The company, led by an academician of the Chinese Academy of Sciences, develops anti-tumor therapies with a global commercialization strategy, having raised over M including a ¥1.2 billion Series B from Warburg Pincus in 2020.

Summary

Haihe Pharmaceutical is a Biotech company based in Shanghai, China, founded in 2011. It has raised $318.0M in total, most recently a $171.0M Series B round in Jul 2020.